Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Non-Current Assets (2016 - 2025)

Conmed's Non-Current Assets history spans 16 years, with the latest figure at $1.7 billion for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 0.8% year-over-year to $1.7 billion; the TTM value through Dec 2025 reached $6.6 billion, down 0.51%, while the annual FY2025 figure was $1.7 billion, 0.8% down from the prior year.
  • Non-Current Assets reached $1.7 billion in Q4 2025 per CNMD's latest filing, roughly flat from $1.7 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $1.7 billion in Q3 2022 to a low of $1.3 billion in Q1 2022.
  • Average Non-Current Assets over 5 years is $1.6 billion, with a median of $1.7 billion recorded in 2024.
  • Peak YoY movement for Non-Current Assets: skyrocketed 31.8% in 2023, then decreased 2.66% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $1.3 billion in 2021, then skyrocketed by 31.43% to $1.7 billion in 2022, then decreased by 1.86% to $1.7 billion in 2023, then dropped by 1.08% to $1.7 billion in 2024, then decreased by 0.8% to $1.7 billion in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Non-Current Assets are $1.7 billion (Q4 2025), $1.7 billion (Q3 2025), and $1.7 billion (Q2 2025).